Will Palantir Crash?
AI and data analytics software major Palantir (NASDAQ:PLTR) has been…
Buy
78
CW Quote, Financials, Valuation and Earnings
Last price:
$470.86
Seasonality move
:
2.47%
Day range:
$468.93 - $479.91
52-week range:
$258.85 - $479.91
Dividend yield:
0.19%
P/E ratio:
41.81x
P/S ratio:
5.59x
P/B ratio:
6.92x
Volume:
463.4K
Avg. volume:
338.3K
1-year change:
76.54%
Market cap:
$17.7B
Revenue:
$3.1B
EPS (TTM):
$11.24
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.6B | $2.8B | $3.1B | |
| Revenue Growth (YoY) | -3.88% | 4.58% | 2.25% | 11.28% | 9.69% | |
| Cost of Revenues | $1.6B | $1.6B | $1.6B | $1.8B | $2B | |
| Gross Profit | $841.2M | $927.8M | $954.6M | $1.1B | $1.2B | |
| Gross Profit Margin | 35.18% | 37.1% | 37.33% | 37.51% | 36.96% | |
| R&D Expenses | $74.8M | $88.5M | $80.8M | $85.8M | $91.6M | |
| Selling, General & Admin | $412.8M | $443.1M | $445.7M | $496.8M | $518.9M | |
| Other Inc / (Exp) | -$55M | -$7M | $8.1M | $29.9M | $23.9M | |
| Operating Expenses | $487.6M | $531.6M | $526.5M | $582.6M | $610.5M | |
| Operating Income | $353.6M | $396.2M | $428.1M | $484.6M | $543M | |
| Net Interest Expenses | $35.5M | $40.2M | $47M | $51.4M | $44.9M | |
| EBT. Incl. Unusual Items | $263.1M | $349M | $389.2M | $463.1M | $522.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $61.7M | $86.1M | $94.8M | $108.6M | $117.1M | |
| Net Income to Company | $201.4M | $262.8M | $294.3M | $354.5M | $405M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $201.4M | $262.8M | $294.3M | $354.5M | $405M | |
| Basic EPS (Cont. Ops) | $4.83 | $6.50 | $7.67 | $9.26 | $10.61 | |
| Diluted EPS (Cont. Ops) | $4.80 | $6.47 | $7.62 | $9.20 | $10.55 | |
| Weighted Average Basic Share | $41.7M | $40.4M | $38.4M | $38.3M | $38.2M | |
| Weighted Average Diluted Share | $42M | $40.6M | $38.6M | $38.5M | $38.4M | |
| EBITDA | $414.5M | $503.6M | $548.2M | $630.6M | $674.6M | |
| EBIT | $298.6M | $389.2M | $436.2M | $514.5M | $566.9M | |
| Revenue (Reported) | $2.4B | $2.5B | $2.6B | $2.8B | $3.1B | |
| Operating Income (Reported) | $353.6M | $396.2M | $428.1M | $484.6M | $543M | |
| Operating Income (Adjusted) | $298.6M | $389.2M | $436.2M | $514.5M | $566.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $597.1M | $559.5M | $630.9M | $713.2M | $805.6M | |
| Revenue Growth (YoY) | -0.69% | -6.3% | 12.76% | 13.05% | 12.97% | |
| Cost of Revenues | $387.3M | $358.1M | $409.5M | $459.4M | $513.2M | |
| Gross Profit | $209.8M | $201.4M | $221.4M | $253.8M | $292.5M | |
| Gross Profit Margin | 35.13% | 36% | 35.1% | 35.58% | 36.3% | |
| R&D Expenses | $21.9M | $20.5M | $22M | $23M | $23M | |
| Selling, General & Admin | $102.8M | $115.7M | $120.8M | $130.8M | $139M | |
| Other Inc / (Exp) | $4.8M | -$1.7M | $7.8M | $9.6M | $4.7M | |
| Operating Expenses | $124.7M | $136.2M | $142.8M | $153.8M | $162M | |
| Operating Income | $85.1M | $65.2M | $78.6M | $100M | $130.5M | |
| Net Interest Expenses | $10M | $9.5M | $12.9M | $10.6M | $10.1M | |
| EBT. Incl. Unusual Items | $80M | $54M | $73.4M | $99M | $125.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20.5M | $13.3M | $16.6M | $22.5M | $23.8M | |
| Net Income to Company | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Basic EPS (Cont. Ops) | $1.45 | $1.06 | $1.48 | $2.00 | $2.69 | |
| Diluted EPS (Cont. Ops) | $1.45 | $1.05 | $1.48 | $1.99 | $2.68 | |
| Weighted Average Basic Share | $40.9M | $38.5M | $38.3M | $38.3M | $37.7M | |
| Weighted Average Diluted Share | $41.1M | $38.7M | $38.5M | $38.4M | $37.9M | |
| EBITDA | $118.5M | $90.9M | $115.3M | $136.6M | $166.1M | |
| EBIT | $89.9M | $63.5M | $86.4M | $109.6M | $135.2M | |
| Revenue (Reported) | $597.1M | $559.5M | $630.9M | $713.2M | $805.6M | |
| Operating Income (Reported) | $85.1M | $65.2M | $78.6M | $100M | $130.5M | |
| Operating Income (Adjusted) | $89.9M | $63.5M | $86.4M | $109.6M | $135.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.4B | $2.5B | $2.6B | $2.9B | $3.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.5B | $1.5B | $1.7B | $1.8B | $2B | |
| Gross Profit | $850.4M | $919.4M | $974.6M | $1.1B | $1.2B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $78.4M | $87.2M | $82.3M | $86.7M | $91.7M | |
| Selling, General & Admin | $407.4M | $456M | $450.8M | $506.9M | $527M | |
| Other Inc / (Exp) | -$54.1M | -$13.5M | $17.5M | $31.7M | $19M | |
| Operating Expenses | $485.8M | $543.1M | $533.1M | $593.6M | $618.7M | |
| Operating Income | $364.6M | $376.3M | $441.5M | $505.9M | $573.6M | |
| Net Interest Expenses | $38M | $39.8M | $50.4M | $49M | $44.4M | |
| EBT. Incl. Unusual Items | $272.5M | $323M | $408.7M | $488.6M | $548.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $63.4M | $78.9M | $98.1M | $114.5M | $118.3M | |
| Net Income to Company | $209.1M | $244M | $310.5M | $374.2M | $429.8M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $209.1M | $244M | $310.5M | $374.2M | $429.8M | |
| Basic EPS (Cont. Ops) | $5.07 | $6.22 | $8.09 | $9.78 | $11.31 | |
| Diluted EPS (Cont. Ops) | $5.04 | $6.18 | $8.04 | $9.71 | $11.24 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $426.9M | $475.9M | $572.6M | $651.9M | $704.1M | |
| EBIT | $310.5M | $362.8M | $459.1M | $537.7M | $592.6M | |
| Revenue (Reported) | $2.4B | $2.5B | $2.6B | $2.9B | $3.2B | |
| Operating Income (Reported) | $364.6M | $376.3M | $441.5M | $505.9M | $573.6M | |
| Operating Income (Adjusted) | $310.5M | $362.8M | $459.1M | $537.7M | $592.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $597.1M | $559.5M | $630.9M | $713.2M | $805.6M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $387.3M | $358.1M | $409.5M | $459.4M | $513.2M | |
| Gross Profit | $209.8M | $201.4M | $221.4M | $253.8M | $292.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $21.9M | $20.5M | $22M | $23M | $23M | |
| Selling, General & Admin | $102.8M | $115.7M | $120.8M | $130.8M | $139M | |
| Other Inc / (Exp) | $4.8M | -$1.7M | $7.8M | $9.6M | $4.7M | |
| Operating Expenses | $124.7M | $136.2M | $142.8M | $153.8M | $162M | |
| Operating Income | $85.1M | $65.2M | $78.6M | $100M | $130.5M | |
| Net Interest Expenses | $10M | $9.5M | $12.9M | $10.6M | $10.1M | |
| EBT. Incl. Unusual Items | $80M | $54M | $73.4M | $99M | $125.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $20.5M | $13.3M | $16.6M | $22.5M | $23.8M | |
| Net Income to Company | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Basic EPS (Cont. Ops) | $1.45 | $1.06 | $1.48 | $2.00 | $2.69 | |
| Diluted EPS (Cont. Ops) | $1.45 | $1.05 | $1.48 | $1.99 | $2.68 | |
| Weighted Average Basic Share | $40.9M | $38.5M | $38.3M | $38.3M | $37.7M | |
| Weighted Average Diluted Share | $41.1M | $38.7M | $38.5M | $38.4M | $37.9M | |
| EBITDA | $118.5M | $90.9M | $115.3M | $136.6M | $166.1M | |
| EBIT | $89.9M | $63.5M | $86.4M | $109.6M | $135.2M | |
| Revenue (Reported) | $597.1M | $559.5M | $630.9M | $713.2M | $805.6M | |
| Operating Income (Reported) | $85.1M | $65.2M | $78.6M | $100M | $130.5M | |
| Operating Income (Adjusted) | $89.9M | $63.5M | $86.4M | $109.6M | $135.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $198.2M | $171M | $257M | $406.9M | $385M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $361.5M | $362M | $412.7M | $427.8M | $479.8M | |
| Inventory | $428.9M | $411.6M | $483.1M | $510M | $541.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $57.4M | $67.1M | $52.6M | $67.5M | $88.1M | |
| Total Current Assets | $1.3B | $1.3B | $1.5B | $1.7B | $1.8B | |
| Property Plant And Equipment | $529.1M | $503.6M | $496.6M | $474.2M | $508.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.6B | $1.7B | |
| Other Intangibles | $609.6M | $538.1M | $620.9M | $557.6M | $596.8M | |
| Other Long-Term Assets | $34.1M | $34.6M | $47.6M | $51.4M | $56M | |
| Total Assets | $4B | $4.1B | $4.4B | $4.6B | $5B | |
| Accounts Payable | $201.2M | $211.6M | $266.5M | $243.8M | $247.2M | |
| Accrued Expenses | $44M | $44.6M | $51.5M | $47.2M | $51.8M | |
| Current Portion Of Long-Term Debt | $100M | -- | $202.5M | -- | $90M | |
| Current Portion Of Capital Lease Obligations | $27.3M | $25.4M | $29.9M | $30.6M | $29.8M | |
| Other Current Liabilities | $47.8M | $51.7M | $19.7M | $20M | $31.7M | |
| Total Current Liabilities | $810.4M | $734.9M | $981M | $806.5M | $1.1B | |
| Long-Term Debt | $948.9M | $1B | $1B | $1B | $958.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.2B | $2.3B | $2.5B | $2.3B | $2.5B | |
| Common Stock | $49.2M | $49.2M | $49.2M | $49.2M | $49.2M | |
| Other Common Equity Adj | -$310.9M | -$190.5M | -$258.9M | -$213.2M | -$243.2M | |
| Common Equity | $1.8B | $1.8B | $2B | $2.3B | $2.4B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $1.8B | $2B | $2.3B | $2.4B | |
| Total Liabilities and Equity | $4B | $4.1B | $4.4B | $4.6B | $5B | |
| Cash and Short Terms | $198.2M | $171M | $257M | $406.9M | $385M | |
| Total Debt | $1B | $1B | $1.2B | $1B | $1B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $147.1M | $136.7M | $130.7M | $338M | $226.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $358.3M | $352.9M | $397.3M | $446.7M | $515.7M | |
| Inventory | $446.6M | $448.1M | $527.9M | $553M | $578.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $48.5M | $63.9M | $67.4M | $69.5M | $84.1M | |
| Total Current Assets | $1.3B | $1.3B | $1.4B | $1.7B | $1.8B | |
| Property Plant And Equipment | $513.9M | $502.6M | $485.3M | $463.2M | $533.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $1.5B | $1.5B | $1.5B | $1.6B | $1.7B | |
| Other Intangibles | $583.2M | $523.9M | $605.2M | $542.3M | $583.1M | |
| Other Long-Term Assets | $32.9M | $33.9M | $48.6M | $49.7M | $55.1M | |
| Total Assets | $4B | $4.1B | $4.4B | $4.6B | $5B | |
| Accounts Payable | $160.8M | $168.8M | $207.6M | $233.8M | $237.7M | |
| Accrued Expenses | $108.5M | $109.1M | $153.7M | $158.1M | $180.8M | |
| Current Portion Of Long-Term Debt | $100M | $202.5M | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | $108.4M | $93.7M | $76.5M | $78.8M | $87.4M | |
| Total Current Liabilities | $734.8M | $800.3M | $672.2M | $858.3M | $953.9M | |
| Long-Term Debt | $957.9M | $967.7M | $1.2B | $960M | $958.6M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1B | $2.2B | $2.3B | $2.2B | $2.4B | |
| Common Stock | $49.2M | $49.2M | $49.2M | $49.2M | $49.2M | |
| Other Common Equity Adj | -$309.2M | -$191.5M | -$244.4M | -$228.3M | -$224.3M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $1.8B | $1.8B | $2.1B | $2.4B | $2.6B | |
| Total Liabilities and Equity | $4B | $4.1B | $4.4B | $4.6B | $5B | |
| Cash and Short Terms | $147.1M | $136.7M | $130.7M | $338M | $226.5M | |
| Total Debt | $1.1B | $1.2B | $1.2B | $1.1B | $958.6M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $201.4M | $262.8M | $294.3M | $354.5M | $405M | |
| Depreciation & Amoritzation | $115.9M | $114.4M | $112M | $116.2M | $107.7M | |
| Stock-Based Compensation | $14.4M | $13.5M | $15.4M | $16.8M | $18.9M | |
| Change in Accounts Receivable | $71.1M | -$61.2M | -$76M | -$2.4M | -$88.8M | |
| Change in Inventories | $15.5M | $13.6M | -$62.6M | -$21.6M | -$34.5M | |
| Cash From Operations | $261.2M | $387.7M | $294.8M | $448.1M | $544.3M | |
| Capital Expenditures | $47.5M | $41.1M | $38.2M | $44.7M | $61M | |
| Cash Acquisitions | -$487.9M | -$5.3M | -$287.5M | -- | -$225.5M | |
| Cash From Investing | -$532.5M | -$42.4M | -$325.9M | -$35.5M | -$283.3M | |
| Dividends Paid (Ex Special Dividend) | -$28.2M | -$28.7M | -$28.8M | -$30.2M | -$31.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $870.7M | $456M | $2B | $638.1M | $21.3M | |
| Long-Term Debt Repaid | -$570.7M | -$462.1M | -$1.8B | -$840.6M | -$21.3M | |
| Repurchase of Common Stock | -$200M | -$343.1M | -$56.9M | -$50.1M | -$250M | |
| Other Financing Activities | -$874K | -$945K | -$1M | -$1.1M | -$1.2M | |
| Cash From Financing | $82.1M | -$369.1M | $129.4M | -$273.4M | -$271.5M | |
| Beginning Cash (CF) | $391M | $198.2M | $171M | $257M | $406.9M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$189.3M | -$23.9M | $98.3M | $139.2M | -$10.5M | |
| Ending Cash (CF) | $198.2M | $171M | $257M | $406.9M | $385M | |
| Levered Free Cash Flow | $213.7M | $346.6M | $256.6M | $403.4M | $483.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Depreciation & Amoritzation | $28.6M | $27.4M | $28.9M | $27M | $30.8M | |
| Stock-Based Compensation | $3.3M | $3.8M | $5.2M | $4.7M | $5.3M | |
| Change in Accounts Receivable | -$27.6M | -$13.4M | $6.1M | -$47.7M | -$72.7M | |
| Change in Inventories | -$18.1M | -$38.1M | -$42.9M | -$45.9M | -$34.1M | |
| Cash From Operations | -$26.6M | -$124.3M | -$91.6M | -$45.6M | -$38.8M | |
| Capital Expenditures | $8.5M | $10.9M | $10.7M | $12.1M | $15.8M | |
| Cash Acquisitions | -$5.3M | -$5.1M | -- | -- | -$9.6M | |
| Cash From Investing | -$12.9M | -$10.4M | -$10.4M | -$12M | -$24.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $65.3M | $241.2M | $465M | $4.9M | $78.1M | |
| Long-Term Debt Repaid | -$65.3M | -$121.2M | -$489.3M | -$4.9M | -$168.1M | |
| Repurchase of Common Stock | -$11.8M | -$18.9M | -$12.4M | -$12.2M | -$14.3M | |
| Other Financing Activities | -$229K | -$248K | -$268K | -$288K | -$309K | |
| Cash From Financing | -$7.1M | $106.2M | -$31.7M | -$7M | -$98.6M | |
| Beginning Cash (CF) | $198.2M | $171M | $257M | $406.9M | $385M | |
| Foreign Exchange Rate Adjustment | -$4.6M | -$5.8M | $7.5M | -$4.2M | $3.7M | |
| Additions / Reductions | -$46.6M | -$28.5M | -$133.8M | -$64.7M | -$162.2M | |
| Ending Cash (CF) | $147.1M | $136.7M | $130.7M | $338M | $226.5M | |
| Levered Free Cash Flow | -$35.1M | -$135.2M | -$102.3M | -$57.7M | -$54.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $209.1M | $244M | $310.5M | $374.2M | $429.8M | |
| Depreciation & Amoritzation | $116.4M | $113.2M | $113.6M | $114.2M | $111.5M | |
| Stock-Based Compensation | $14.4M | $13.9M | $16.8M | $16.3M | $19.5M | |
| Change in Accounts Receivable | $45.2M | -$47M | -$56.4M | -$56.3M | -$113.8M | |
| Change in Inventories | $21.6M | -$6.5M | -$67.3M | -$24.5M | -$22.7M | |
| Cash From Operations | $427.2M | $290M | $327.5M | $494.1M | $551.1M | |
| Capital Expenditures | $37.4M | $43.5M | $38M | $46.1M | $64.7M | |
| Cash Acquisitions | -$442.2M | -$5.1M | -$282.4M | -- | -$235.2M | |
| Cash From Investing | -$477.7M | -$39.9M | -$325.9M | -$37.1M | -$296.2M | |
| Dividends Paid (Ex Special Dividend) | -$28.2M | -$28.7M | -$28.8M | -$30.2M | -$31.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $747.3M | $631.8M | $2.2B | $178M | $94.5M | |
| Long-Term Debt Repaid | -$593.7M | -$517.9M | -$2.2B | -$356.2M | -$184.5M | |
| Repurchase of Common Stock | -$99.8M | -$350.2M | -$50.4M | -$49.9M | -$252.1M | |
| Other Financing Activities | -$891K | -$964K | -$1M | -$1.1M | -$1.2M | |
| Cash From Financing | $35.7M | -$255.8M | -$8.5M | -$248.7M | -$363.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$14.9M | -$5.8M | -$6.9M | $208.3M | -$108.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $389.8M | $246.5M | $289.5M | $448M | $486.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $59.5M | $40.7M | $56.8M | $76.5M | $101.3M | |
| Depreciation & Amoritzation | $28.6M | $27.4M | $28.9M | $27M | $30.8M | |
| Stock-Based Compensation | $3.3M | $3.8M | $5.2M | $4.7M | $5.3M | |
| Change in Accounts Receivable | -$27.6M | -$13.4M | $6.1M | -$47.7M | -$72.7M | |
| Change in Inventories | -$18.1M | -$38.1M | -$42.9M | -$45.9M | -$34.1M | |
| Cash From Operations | -$26.6M | -$124.3M | -$91.6M | -$45.6M | -$38.8M | |
| Capital Expenditures | $8.5M | $10.9M | $10.7M | $12.1M | $15.8M | |
| Cash Acquisitions | -$5.3M | -$5.1M | -- | -- | -$9.6M | |
| Cash From Investing | -$12.9M | -$10.4M | -$10.4M | -$12M | -$24.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $65.3M | $241.2M | $465M | $4.9M | $78.1M | |
| Long-Term Debt Repaid | -$65.3M | -$121.2M | -$489.3M | -$4.9M | -$168.1M | |
| Repurchase of Common Stock | -$11.8M | -$18.9M | -$12.4M | -$12.2M | -$14.3M | |
| Other Financing Activities | -$229K | -$248K | -$268K | -$288K | -$309K | |
| Cash From Financing | -$7.1M | $106.2M | -$31.7M | -$7M | -$98.6M | |
| Beginning Cash (CF) | $198.2M | $171M | $257M | $406.9M | $385M | |
| Foreign Exchange Rate Adjustment | -$4.6M | -$5.8M | $7.5M | -$4.2M | $3.7M | |
| Additions / Reductions | -$46.6M | -$28.5M | -$133.8M | -$64.7M | -$162.2M | |
| Ending Cash (CF) | $147.1M | $136.7M | $130.7M | $338M | $226.5M | |
| Levered Free Cash Flow | -$35.1M | -$135.2M | -$102.3M | -$57.7M | -$54.5M | |
Get CW Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CW
Sector
P/E ratio
41.81x
17.76x
PEG ratio
2.65x
0.25x
P/B ratio
6.92x
1.72x
Price / LTM sales
5.59x
0.93x
Growth Metrics
CW
Sector
Revenue growth
12.97%
1.95%
Earnings growth
34.67%
3.23%
Revenue (5-year growth)
4.64%
4.39%
Earnings forecast
$2.39
$0.28
Profitability
CW
Sector
Profitability FY 2024
$1.2B
$397.8M
Return on invested capital
12.28%
5.35%
Return on assets
8.89%
3.54%
Return on equity
17.42%
8.69%
Earnings Date
Last Earnings Date
May
7
Next Earnings Date
Aug
7
Estimated Next Earnings Date
Aug
6
Balance Sheet
CW
Sector
Total cash
$226.5M
$160.2M
Short term investments
--
$36.5M
Total assets
$5B
$1.8B
Long term debt
$958.6M
$273.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Target’s Dividend Worth Buying?
Retail giant Target (NYSE:TGT) has been through an extremely volatile…
Where Will AST SpaceMobile Be In 5 Years?
Ever tried to send a text from the Nevada desert…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
37
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
49
RGC alert for Jun 17
Regencell Bioscience Holdings [RGC] is up 30.75% over the past day.
Buy
59
SYM alert for Jun 17
Symbotic [SYM] is down 3.3% over the past day.
Sell
43
TNXP alert for Jun 17
Tonix Pharmaceuticals Holding [TNXP] is down 5.6% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
